Histamine and H1-histamine receptors faster venous circulation

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 12, 2011, Pages 2614-2623

  Galajda, Zoltan ^a   Balla, Jozsef ^a   Szentmiklosi, A Jozsef ^a   Biro, Tamas ^a   Czifra, Gabriella ^a   Dobrosi, Nora ^a   Cseppento, Agnes ^a   Patonay, Lajos ^b   Roszer, Tamas ^c   Balla, Gyorgy ^a   Popescu, Laurenciu M ^d   Lekli, Istvan ^a   Tosaki, Arpad ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^d CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

kinase; H1 histamine receptors; Histamine; Regional differences; Tyrosine phosphorylation; Venous regulation

Indexed keywords

HEME OXYGENASE 1; HISTAMINE; HISTAMINE H1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL; ARTICLE; ENZYME IMMUNOASSAY; FEMORAL VEIN; INFERIOR CAVA VEIN; MALE; METABOLISM; PHYSIOLOGY; RABBIT; SAPHENOUS VEIN; VASOCONSTRICTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; FEMORAL VEIN; HEME OXYGENASE-1; HISTAMINE; IMMUNOENZYME TECHNIQUES; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; RABBITS; RECEPTORS, HISTAMINE H1; SAPHENOUS VEIN; VASOCONSTRICTION; VENA CAVA, INFERIOR;

EID: 82455174750     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01254.x     Document Type: Article

References (53)

1. Rothe CF. Venous system: physiology of the capacitance vessels. In: JT Shepherd, FM Abboud, editors. Handbook of physiology: the cardiovascular system, peripheral circulation. Washington, DC: Am. Physiol. Soc.; 1983. Sect. 2, Vol. III, Chap. 13, p. 397-452.
2. Pang CCY. Autonomic control of the venous system in health and disease. Effects of drugs. Pharmacol Ther. 2001; 90: 179-230.
3. Donegan JF. The physiology of veins. J Physiol. 1921; 55: 226-45.
4. Ludbrook J. The musculovenous pumps of the human lower limb. Am Heart J. 1966; 71: 635-41.
5. Noordergraaf A. Veins. In: Circulatory system dynamics. New York: Academic Press; 1978. pp. 157-81.
6. Rothe CF. Physiology of venous return. An unappreciated boost to the heart. Arch Intern Med. 1986; 146: 977-82.
7. Monos E, Berczi V, Nadasy G. Local control of veins: biomechanical, metabolic, and humoral aspects. Physiol Rev. 1995; 75: 611-66.
8. Burch GE, DePasquale NP. The effect of norepinephrine on the digital veins. Am Heart J. 1960; 60: 915-23.
9. Cohen ML, Wiley KS. Comparison of arteries with longitudinal and circular venous muscle from the rat. Am J Physiol. 1977; 232: H131-9.
10. Sticht FD, Wood WB, Cardoso SS, et al. Effect of prazosin on veins: inhibition of norepinephrine venoconstriction in dog forelimb. Drug Dev Res. 1983; 3: 393-488.
11. Hohmann M, Keve TM, Osol G, et al. Norepinephrine sensitivity of mesenteric veins in pregnant rats. Am J Physiol. 1990; 259: R753-9.
12. Zhang L, Dyer DC. Characterization of alpha-adrenoceptors mediating contraction in isolated ovine umbilical vein. Eur J Pharmacol. 1991; 197: 63-7.
13. Errasti AE, Werneck de Avellar MC, Daray FM, et al. Human umbilical vein vasoconstriction induced by epinephrine acting on alpha1B-adrenoceptor subtype. Am J Obstet Gynecol. 2003; 189: 1472-80.
14. Miller JW, Streeten DH. Vascular responsiveness to norepinephrine in sympathicotonic orthostatic intolerance. J Lab Clin Med. 1990; 115: 549-58.
15. Nilsson H. Adrenergic nervous control of resistance and capacitance vessels. Studies on isolated blood vessels from the rat. Acta Physiol Scand. Suppl. 1985; 541: 1-34.
16. Arneklo-Nobin B, Owman C. Adrenergic and serotoninergic mechanisms in human hand arteries and veins studied by fluorescence histochemistry andin vitropharmacology. Blood Vessels. 1985; 22: 1-12.
17. Savino EA, Taquini AC Jr. Effects of adrenaline, angiotensin, potassium and calcium on lanthanum treated portal veins. Arch Int Pharmacodyn Ther. 1977; 226: 100-8.
18. Mantel R, Taquini AC Jr, Savino EA. Effects of adrenaline, angiotensin and calcium on spontaneously active and potassium-depolarized rat portal veins. Arch Int Physiol Biochim. 1975; 83: 211-9.
19. Gurzu B, Costuleanu M, Slatineanu SM, et al. Are multiple angiotensin receptor types involved in angiotensin (1-7) actions on isolated rat portal vein. J Renin Angiotensin Aldosterone Syst. 2005; 6: 90-5.
20. Fernandes L, Loiola RA, Tostes RC, et al. Angiotensin II-induced venoconstriction involves both AT1 and AT2 receptors and is counterbalanced by nitric oxide. Peptides. 2005; 26: 2458-63.
21. Li Q, Feenstra M, Pfaffendorf M, et al. Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein. J Cardiovasc Pharmacol. 1997; 29: 451-6.
22. Pelet C, Mironneau C, Rakotoarisoa L, et al. Angiotensin II receptor subtypes and contractile responses in portal vein smooth muscle. Eur J Pharmacol. 1995; 279: 15-24.
23. Zhang JS, Van Meel JC, Pfaffendorf M, et al. Characterization of the angiotensin II-receptor subtype in the longitudinal smooth muscle of the rat portal vein. Naunyn Schmiedebergs Arch Pharmacol. 1993; 347: 220-4.
24. Blair-West JR, McKenzie JS, McKinley MJ. The actions of angiotensin II on the isolated portal vein of the rat. Eur J Pharmacol. 1971; 15: 221-30.
25. Bogoni G, Rizzi A, Calo G, et al. Characterization of endothelin receptors in the human umbilical artery and vein. Br J Pharmacol. 1996; 119: 1600-4.
26. Mawatari K, Komori K, Kuma S, et al. Effects of serotonin and endothelin on the smooth muscle cells of autogenous vein grafts. Br J Surg. 1997; 84: 1419-24.
27. Wang HG, Shibamoto T, Miyahara T. Endothelin-1 selectively contracts portal vein through both ETA and ETB receptors in isolated rabbit liver. Am J Physiol. 1997; 273: G1036-43.
28. Rizzi A, Calo G, Battistini B, et al. Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities. J Cardiovasc Pharmacol. 1998; 31: S58-61.
29. Ziganshin AU, Khaziakhmetov DF, Ziganshina LE, et al. Contractile activity of human greater saphenous vein mediated by P2-receptors. Bull Exp Biol Med. 2003; 135: 23-5.
30. Ralevic V, Burnstock G. Roles of P2-purinoceptors in the cardiovascular system. Circulation. 1991; 84: 1-14.
31. Monos E, Lorant M, Dornyei G, et al. Long-term adaptation mechanisms in extremity veins supporting orthostatic tolerance. News Physiol Sci. 2003; 18: 210-4.
32. Okamura T, Yamazaki M, Toda N. Responses to histamine and acetylcholine in isolated monkey mesenteric veinsversusarteries. Cardiovasc Res. 1994; 28: 667-72.
33. Mikkelsen E, Sakr AM, Jespersen LT. Studies on the effect of histamine in isolated human pulmonary arteries and veins. Acta Pharmacol Toxicol. 1984; 54: 86-93.
34. Schoeffter P, Godfraind T. Histamine receptors in the smooth muscle of human internal mammary artery and saphenous vein. Pharmacol Toxicol. 1989; 64: 64-71.
35. Diana JN, Schwinghamer J, Young S. Direct effect of histamine on arterial and venous resistance in isolated dog hindlimb. Am J Physiol. 1968; 214: 494-505.
36. Cook DA, Macleod KM. Responses of rabbit portal vein to histamine. Br J Pharmacol. 1978; 62: 165-70.
37. Toshimitsu Y, Uchida K, Kojima S, et al. Histamine responses mediatedviaH1- and H2-receptors in the isolated portal vein of the dog. J Pharm Pharmacol. 1984; 36: 404-5.
38. Oriowo MA, Bevan JA. Characterization of histamine H1 and H2 receptors in the rabbit isolated ovarian artery and vein. J Cardiovasc Pharmacol. 1987; 10: 76-81.
39. Tsuru H, Kohno S, Iwata M, et al. Characterization of histamine receptors in isolated rabbit veins. J Pharmacol Exp Ther. 1987; 243: 696-702.
40. Bergner M, Graser T, Handschuk L, et al. Vasomotor tone of isolated porcine coronary veins in response to acetylcholine, noradrenaline, and histamine. Biomed Biochim Acta. 1988; 47: 775-9.
41. Bodo E, Kovacs I, Telek A, et al. Vanilloid receptor-1 (VR1) is widely expressed on various epithelial and mesenchymal cell types of human skin. J Invest Dermatol. 2004; 123: 410-3.
42. Bodo E, Biro T, Telek A, et al. A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control. Am J Pathol. 2005; 166: 985-98.
43. Biro T, Maurer M, Modarres S, et al. Characterization of functional vanilloid receptors expressed by mast cells. Blood. 1998; 91: 1332-40.
44. Anichtchik OV, Rinne JO, Kalimo H, et al. An altered histaminergic innervation of the substantia nigra in Parkinson's disease. Exp Neurol. 2000; 163: 20-30.
45. Rinne JO, Anichtchik OV, Eriksson KS, et al. Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy. J Neurochem. 2002; 81: 954-60.
46. Berczi V, Greene AS, Dornyei G, et al. Venous myogenic tone: studies in human and canine vessels. Am J Physiol Heart Circ Physiol. 1992; 263: H315-20.
47. Champion HC, Bivalacqua TJ, Lambert DG, et al. Analysis of vasoconstrictor responses to histamine in the hindlimb vascular bed of the rabbit. Am J Physiol. 1999; 277: R1179-87.
48. Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci. 2001; 22: 32-9.
49. Walsh MP. Calmodulin and the regulation of smooth muscle contraction. Mol Cell Biochem. 1994; 135: 21-41.
50. Somlyo AP, Wu X, Walker LA, et al. Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatases. Rev Physiol Biochem Pharmacol. 1999; 134: 201-34.
51. Hughes AD, Wijetunge S. Role of tyrosine phosphorylation in excitation-contraction coupling in vascular smooth muscle. Acta Physiol Scand. 1998; 164: 457-69.
52. Ferdinandy P. Peroxynitrite: just an oxidative/nitrosative stressor or a physiological regulator as well Br J Pharmacol. 2006; 148: 1-3.
53. Gruetter CA, Bailey B, Easterling L, et al. Release of non-mast cell histamine from rat aorta. Life Sci. 2002; 70: 1709-17.